These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15086185)

  • 1. Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
    Nahamura H; Yoshida K; Kishima Y; Enomoto H; Uyama H; Kuroda T; Okuda Y; Hirotani T; Ito H; Kawase I
    Hepatogastroenterology; 2004; 51(56):470-5. PubMed ID: 15086185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis.
    Nakamura H; Yoshida K; Ikegame K; Kishima Y; Uyama H; Enomoto H
    J Gastroenterol; 2002 Nov; 37 Suppl 14():8-14. PubMed ID: 12572860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients.
    Zhang A; Long W; Guo Z; Liu G; Hu Z; Huang Y; Li Y; Grabinski TM; Yang J; Zhao PX; Everett AD; Zhang Y; Cao BB
    J Immunol Methods; 2010 Apr; 355(1-2):61-7. PubMed ID: 20193688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies.
    Kuwabara N; Itoh Y; Igarshi T; Fukunaga Y
    Autoimmunity; 2009 Sep; 42(6):492-6. PubMed ID: 19657776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
    Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
    J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
    Ebert EC; Geng X; Lin J; Das KM
    Cell Immunol; 2006 Nov; 244(1):43-9. PubMed ID: 17416356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
    Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
    Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.
    Rubinstein A; Das KM; Melamed J; Murphy RA
    Clin Exp Immunol; 1978 Aug; 33(2):217-24. PubMed ID: 31252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
    Lepourcelet M; Tou L; Cai L; Sawada J; Lazar AJ; Glickman JN; Williamson JA; Everett AD; Redston M; Fox EA; Nakatani Y; Shivdasani RA
    Development; 2005 Jan; 132(2):415-27. PubMed ID: 15604097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating autoantibodies against purified colonic mucin in ulcerative colitis.
    Takaishi H; Ohara S; Hotta K; Yajima T; Kanai T; Inoue N; Iwao Y; Watanabe M; Ishii H; Hibi T
    J Gastroenterol; 2000; 35(1):20-7. PubMed ID: 10632536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.
    Bamba T; Matsuda H; Endo M; Fujiyama Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():45-7. PubMed ID: 8563888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
    Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
    Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
    Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study.
    Carroccio A; Brusca I; Iacono G; Alessio MG; Sonzogni A; Di Prima L; Barrale M; Ottomano C; Ambrosiano G; Teresi S; D'Angelo A; Pirrone G; Cefalù B; Scalici C; La Chiusa SM
    Dig Liver Dis; 2007 Sep; 39(9):818-23. PubMed ID: 17652043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.